{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:51:35Z","timestamp":1792511495983,"version":"4.5.0"},"reference-count":45,"publisher":"Pleiades Publishing Ltd","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochemistry Moscow"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1134\/s0006297925602795","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T14:25:25Z","timestamp":1770733525000},"page":"39-47","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Molecular Mechanisms of Antibody-Dependent Enhancement of Viral Infection"],"prefix":"10.1134","volume":"91","author":[{"given":"Alexander V.","family":"Filatov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G.","family":"Byazrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria M.","family":"Sukhova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey G.","family":"Prilipov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"137","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"2968_CR1","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/icb.1964.44","volume":"42","author":"R. A. Hawkes","year":"1964","unstructured":"Hawkes, R. A. (1964) Enhancement of the infectivity of arboviruses by specific antisera produced in domestic fowls, Aust. J. Exp. Biol. Med., 42, 465-482, \nhttps:\/\/doi.org\/10.1038\/icb.1964.44.","journal-title":"Aust. J. Exp. Biol. Med."},{"key":"2968_CR2","doi-asserted-by":"publisher","unstructured":"Kulkarni, R. (2020) Antibody-dependent enhancement of viral infections, in Dynamics of Immune Activation in Viral Diseases (Bramhachari, P.\u00a0V., ed.) Singapore: Springer Singapore, p.\u00a09-41, \nhttps:\/\/doi.org\/10.1007\/978-981-15-1045-8_2.","DOI":"10.1007\/978-981-15-1045-8_2"},{"key":"2968_CR3","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1084\/jem.20020781","volume":"196","author":"F. P. Polack","year":"2002","unstructured":"Polack, F. P., Teng, M. N., Collins, P. L., Prince, G. A., Exner, M., Regele, H., Lirman, D. D., Rabold, R., Hoffman, S. J., Karp, C. L., Kleeberger, S. R., Wills-Karp, M., and Karron, R. A. (2002) A role for immune complexes in enhanced respiratory syncytial virus disease, J. Exp. Med., 196, 859-865, \nhttps:\/\/doi.org\/10.1084\/jem.20020781.","journal-title":"J. Exp. Med."},{"key":"2968_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005817","volume":"12","author":"M. Z. Tay","year":"2016","unstructured":"Tay, M. Z., Liu, P., Williams, L. D., McRaven, M. D., Sawant, S., Gurley, T. C., Xu, T. T., Dennison, S. M., Liao, H. X., Chenine, A. L., Alam, S. M., Moody, M. A., Hope, T. J., Haynes, B. F., and Tomaras, G. D. (2016) Antibody-mediated internalization of infectious HIV-1 virions differs among antibody isotypes and subclasses, PLoS Pathog., 12, e1005817, \nhttps:\/\/doi.org\/10.1371\/journal.ppat.1005817.","journal-title":"PLoS Pathog."},{"key":"2968_CR5","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3006366","volume":"5","author":"S. Khurana","year":"2013","unstructured":"Khurana, S., Loving, C. L., Manischewitz, J., King, L. R., Gauger, P. C., Henningson, J., Vincent, A. L., and Golding, H. (2013) Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease, Sci. Transl. Med., 5, 200ra114, \nhttps:\/\/doi.org\/10.1126\/scitranslmed.3006366.","journal-title":"Sci. Transl. Med."},{"key":"2968_CR6","doi-asserted-by":"publisher","first-page":"7539","DOI":"10.1128\/jvi.77.13.7539-7544.2003","volume":"77","author":"A. Takada","year":"2003","unstructured":"Takada, A., Feldmann, H., Ksiazek, T. G., and Kawaoka, Y. (2003) Antibody-dependent enhancement of Ebola virus infection, J. Virol., 77, 7539-7544, \nhttps:\/\/doi.org\/10.1128\/jvi.77.13.7539-7544.2003.","journal-title":"J. Virol."},{"key":"2968_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/v14081739","volume":"14","author":"X. Yang","year":"2022","unstructured":"Yang, X., Zhang, X., Zhao, X., Yuan, M., Zhang, K., Dai, J., Guan, X., Qiu, H. J., and Li, Y. (2022) Antibody-dependent enhancement: \u201cevil\u201d antibodies favorable for viral infections, Viruses, 14, 1739, \nhttps:\/\/doi.org\/10.3390\/v14081739.","journal-title":"Viruses"},{"key":"2968_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-20305-4","volume":"8","author":"F. M. Lum","year":"2018","unstructured":"Lum, F. M., Couderc, T., Chia, B. S., Ong, R. Y., Her, Z., Chow, A., Leo, Y. S., Kam, Y. W., R\u00e9nia, L., Lecuit, M., and Ng, L. F. P. (2018) Antibody-mediated enhancement aggravates chikungunya virus infection and disease severity, Sci. Rep., 8, 1860, \nhttps:\/\/doi.org\/10.1038\/s41598-018-20305-4.","journal-title":"Sci. Rep."},{"key":"2968_CR9","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1126\/science.aan6836","volume":"358","author":"L. C. Katzelnick","year":"2017","unstructured":"Katzelnick, L. C., Gresh, L., Halloran, M. E., Mercado, J. C., Kuan, G., Gordon, A., Balmaseda, A., and Harris, E. (2017) Antibody-dependent enhancement of severe dengue disease in humans, Science, 358, 929-932, \nhttps:\/\/doi.org\/10.1126\/science.aan6836.","journal-title":"Science"},{"key":"2968_CR10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1126\/science.aal4365","volume":"356","author":"S. V. Bardina","year":"2017","unstructured":"Bardina, S. V., Bunduc, P., Tripathi, S., Duehr, J., Frere, J. J., Brown, J. A., Nachbagauer, R., Foster, G. A., Krysztof, D., Tortorella, D., Stramer, S. L., Garc\u00eda-Sastre, A., Krammer, F., and Lim, J. K. (2017) Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity, Science, 356, 175-180, \nhttps:\/\/doi.org\/10.1126\/science.aal4365.","journal-title":"Science"},{"key":"2968_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1084\/jem.146.1.201","volume":"146","author":"S. B. Halstead","year":"1977","unstructured":"Halstead, S. B., and O'Rourke, E. J. (1977) Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody, J. Exp. Med., 146, 201-217, \nhttps:\/\/doi.org\/10.1084\/jem.146.1.201.","journal-title":"J. Exp. Med."},{"key":"2968_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri2206","volume":"8","author":"F. Nimmerjahn","year":"2008","unstructured":"Nimmerjahn, F., and Ravetch, J. V., (2008) Fc\u03b3 receptors as regulators of immune responses, Nat. Rev. Immunol., 8, 34-47, \nhttps:\/\/doi.org\/10.1038\/nri2206.","journal-title":"Nat. Rev. Immunol."},{"key":"2968_CR13","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1586\/14760584.2016.1121814","volume":"15","author":"E. G. Acosta","year":"2016","unstructured":"Acosta, E. G., and Bartenschlager, R. (2016) Paradoxical role of antibodies in dengue virus infections: considerations for prophylactic vaccine development, Expert Rev. Vaccines, 15, 467-482, \nhttps:\/\/doi.org\/10.1586\/14760584.2016.1121814.","journal-title":"Expert Rev. Vaccines"},{"key":"2968_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006139","volume":"12","author":"W. Furuyama","year":"2016","unstructured":"Furuyama, W., Marzi, A., Carmody, A. B., Maruyama, J., Kuroda, M., Miyamoto, H., Nanbo, A., Manzoor, R., Yoshida, R., Igarashi, M., Feldmann, H., and Takada, A. (2016) Fc\u03b3-receptor IIa-mediated Src signaling pathway is essential for the antibody-dependent enhancement of Ebola virus infection, PLoS Pathog., 12, e1006139, \nhttps:\/\/doi.org\/10.1371\/journal.ppat.1006139.","journal-title":"PLoS Pathog."},{"key":"2968_CR15","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1021\/acschembio.8b00342","volume":"13","author":"D. J. Falconer","year":"2018","unstructured":"Falconer, D. J., Subedi, G. P., Marcella, A. M., and Barb, A. W. (2018) Antibody fucosylation lowers the Fc\u03b3RIIIa\/CD16a affinity by limiting the conformations sampled by the N162-glycan, ACS Chem. Biol., 13, 2179-2189, \nhttps:\/\/doi.org\/10.1021\/acschembio.8b00342.","journal-title":"ACS Chem. Biol."},{"key":"2968_CR16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1126\/science.aai8128","volume":"355","author":"T. T. Wang","year":"2017","unstructured":"Wang, T. T., Sewatanon, J., Memoli, M. J., Wrammert, J., Bournazos, S., Bhaumik, S. K., Pinsky, B. A., Chokephaibulkit, K., Onlamoon, N., Pattanapanyasat, K., Taubenberger, J. K., Ahmed, R., and Ravetch, J. V. (2017) IgG antibodies to dengue enhanced for Fc\u03b3RIIIA binding determine disease severity, Science, 355, 395-398, \nhttps:\/\/doi.org\/10.1126\/science.aai8128.","journal-title":"Science"},{"key":"2968_CR17","doi-asserted-by":"publisher","first-page":"12479","DOI":"10.1073\/pnas.1106568108","volume":"108","author":"K. R. Chan","year":"2011","unstructured":"Chan, K. R., Zhang, S. L., Tan, H. C., Chan, Y. K., Chow, A., Lim, A. P., Vasudevan, S. G., Hanson, B. J., and Ooi, E. E. (2011) Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection, Proc. Natl. Acad. Sci. USA, 108, 12479-12484, \nhttps:\/\/doi.org\/10.1073\/pnas.1106568108.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2968_CR18","doi-asserted-by":"publisher","first-page":"5659","DOI":"10.4049\/jimmunol.1203052","volume":"190","author":"K. Boonnak","year":"2013","unstructured":"Boonnak, K., Slike, B. M., Donofrio, G. C., and Marovich, M. A. (2013) Human Fc\u03b3RII cytoplasmic domains differentially influence antibody-mediated dengue virus infection, J.\u00a0Immunol., 190, 5659-5665, \nhttps:\/\/doi.org\/10.4049\/jimmunol.1203052.","journal-title":"J.\u00a0Immunol."},{"key":"2968_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-022-03207-0","volume":"5","author":"S. Wang","year":"2022","unstructured":"Wang, S., Wang, J., Yu, X., Jiang, W., Chen, S., Wang, R., Wang, M., Jiao, S., Yang, Y., Wang, W., Chen, H., Chen, B., Gu, C., Liu, C., Wang, A., Wang, M., Li, G., Guo, C., Liu, D., Zhang, J., and Gui, X. (2022) Antibody-dependent enhancement (ADE) of SARS-CoV-2 pseudoviral infection requires Fc\u03b3RIIB and virus-antibody complex with bivalent interaction, Commun. Biol., 5, 262, \nhttps:\/\/doi.org\/10.1038\/s42003-022-03207-0.","journal-title":"Commun. Biol."},{"key":"2968_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0267796","volume":"17","author":"R. V. House","year":"2022","unstructured":"House, R. V., Broge, T. A., Suscovich, T. J., Snow, D. M., Tomic, M. T., Nonet, G., Bajwa, K., Zhu, G., Martinez, Z., Hackett, K., Earnhart, C. G., Dorsey, N. M., Hopkins, S. A., Natour, D. S., Davis, H. D., Anderson, M. S., Gainey, M. R., and Cobb, R. R. (2022) Evaluation of strategies to modify Anti-SARS-CoV-2 monoclonal antibodies for optimal functionality as therapeutics, PLoS One, 17, e0267796, \nhttps:\/\/doi.org\/10.1371\/journal.pone.0267796.","journal-title":"PLoS One"},{"key":"2968_CR21","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2022.2152526","volume":"15","author":"A. Dippel","year":"2023","unstructured":"Dippel, A., Gallegos, A., Aleti, V., Barnes, A., Chen, X., Christian, E., Delmar, J., Du, Q., Esfandiary, R., Farmer, E., Garcia, A., Li, Q., Lin, J., Liu, W., Machiesky, L., Mody, N., Parupudi, A., Prophet, M., Rickert, K., Rosenthal, K., and Kaplan, G. (2023) Developability profiling of a panel of Fc engineered SARS-CoV-2 neutralizing antibodies, mAbs, 15, 2152526, \nhttps:\/\/doi.org\/10.1080\/19420862.2022.2152526.","journal-title":"mAbs"},{"key":"2968_CR22","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1016\/j.celrep.2018.07.035","volume":"24","author":"N. A. Kuzmina","year":"2018","unstructured":"Kuzmina, N. A., Younan, P., Gilchuk, P., Santos, R. I., Flyak, A. I., Ilinykh, P. A., Huang, K., Lubaki, N. M., Ramanathan, P., Crowe, J. E., Jr, and Bukreyev, A. (2018) Antibody-dependent enhancement of Ebola virus infection by human antibodies isolated from survivors, Cell Rep., 24, 1802-1815.e5, \nhttps:\/\/doi.org\/10.1016\/j.celrep.2018.07.035.","journal-title":"Cell Rep."},{"key":"2968_CR23","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1128\/jvi.80.3.1290-1301.2006","volume":"80","author":"C. W. Davis","year":"2006","unstructured":"Davis, C. W., Nguyen, H. Y., Hanna, S. L., S\u00e1nchez, M. D., Doms, R. W., and Pierson, T. C. (2006) West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection, J. Virol., 80, 1290-1301, \nhttps:\/\/doi.org\/10.1128\/jvi.80.3.1290-1301.2006.","journal-title":"J. Virol."},{"key":"2968_CR24","doi-asserted-by":"publisher","first-page":"8426","DOI":"10.1073\/pnas.1019030108","volume":"108","author":"A. S. Kondratowicz","year":"2011","unstructured":"Kondratowicz, A. S., Lennemann, N. J., Sinn, P. L., Davey, R. A., Hunt, C. L., Moller-Tank, S., Meyerholz, D. K., Rennert, P., Mullins, R. F., Brindley, M., Sandersfeld, L. M., Quinn, K., Weller, M., McCray, P. B., Jr., Chiorini, J., and Maury, W. (2011) T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus, Proc. Natl. Acad. Sci. USA, 108, 8426-8431, \nhttps:\/\/doi.org\/10.1073\/pnas.1019030108.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2968_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1099\/vir.0.014829-0","volume":"91","author":"M. L. Moi","year":"2010","unstructured":"Moi, M. L., Lim, C. K., Takasaki, T., and Kurane, I. (2010) Involvement of the Fc gamma receptor IIA cytoplasmic domain in antibody-dependent enhancement of dengue virus infection, J. Gen. Virol., 91, 103-111, \nhttps:\/\/doi.org\/10.1099\/vir.0.014829-0.","journal-title":"J. Gen. Virol."},{"key":"2968_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.chom.2007.03.002","volume":"1","author":"T. C. Pierson","year":"2007","unstructured":"Pierson, T. C., Xu, Q., Nelson, S., Oliphant, T., Nybakken, G. E., Fremont, D. H., and Diamond, M.\u00a0S. (2007) The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection, Cell Host Microbe, 1, 135-145, \nhttps:\/\/doi.org\/10.1016\/j.chom.2007.03.002.","journal-title":"Cell Host Microbe"},{"key":"2968_CR27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/imr.13393","volume":"328","author":"J. E. Edgar","year":"2024","unstructured":"Edgar, J. E., and Bournazos, S. (2024) Fc-Fc\u03b3R interactions during infections: from neutralizing antibodies to antibody-dependent enhancement, Immunol. Rev., 328, 221-242, \nhttps:\/\/doi.org\/10.1111\/imr.13393.","journal-title":"Immunol. Rev."},{"key":"2968_CR28","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/imr.12367","volume":"268","author":"A. Taylor","year":"2015","unstructured":"Taylor, A., Foo, S. S., Bruzzone, R., Dinh, L. V., King, N. J., and Mahalingam, S. (2015) Fc receptors in antibody-dependent enhancement of viral infections, Immunol. Rev., 268, 340-364, \nhttps:\/\/doi.org\/10.1111\/imr.12367.","journal-title":"Immunol. Rev."},{"key":"2968_CR29","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1002\/eji.200636195","volume":"36","author":"A. D. Barrow","year":"2006","unstructured":"Barrow, A. D., and Trowsdale, J. (2006) You say ITAM and I say ITIM, let\u2019s call the whole thing off: the ambiguity of immunoreceptor signalling, Eur. J. Immunol., 36, 1646-1653, \nhttps:\/\/doi.org\/10.1002\/eji.200636195.","journal-title":"Eur. J. Immunol."},{"key":"2968_CR30","doi-asserted-by":"publisher","first-page":"8085","DOI":"10.1016\/j.vaccine.2010.10.004","volume":"28","author":"O. K. Block","year":"2010","unstructured":"Block, O. K., Rodrigo, W. W., Quinn, M., Jin, X., Rose, R. C., and Schlesinger, J. J. (2010) A tetravalent recombinant dengue domain III protein vaccine stimulates neutralizing and enhancing antibodies in mice, Vaccine, 28, 8085-8094, \nhttps:\/\/doi.org\/10.1016\/j.vaccine.2010.10.004.","journal-title":"Vaccine"},{"key":"2968_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11071240","volume":"11","author":"J. Sawant","year":"2023","unstructured":"Sawant, J., Patil, A., and Kurle, S. (2023) A Review: understanding molecular mechanisms of antibody-dependent enhancement in viral infections, Vaccines, 11, 1240, \nhttps:\/\/doi.org\/10.3390\/vaccines11071240.","journal-title":"Vaccines"},{"key":"2968_CR32","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.1248943","volume":"343","author":"C. A. Diebolder","year":"2014","unstructured":"Diebolder, C. A., Beurskens, F. J., de Jong, R. N., Koning, R. I., Strumane, K., Lindorfer, M. A., Voorhorst, M., Ugurlar, D., Rosati, S., Heck, A. J., van de Winkel, J. G., Wilson, I. A., Koster, A. J., Taylor, R. P., Saphire, E. O., Burton, D. R., Schuurman, J., Gros, P., and Parren, P. W. (2014) Complement is activated by IgG hexamers assembled at the cell surface, Science, 343, 1260-1263, \nhttps:\/\/doi.org\/10.1126\/science.1248943.","journal-title":"Science"},{"key":"2968_CR33","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.ijid.2020.12.039","volume":"103","author":"A. B. Byrne","year":"2021","unstructured":"Byrne, A. B., and Talarico, L. B. (2021) Role of the complement system in antibody-dependent enhancement of flavivirus infections, Int. J. Infect. Dis., 103, 404-411, \nhttps:\/\/doi.org\/10.1016\/j.ijid.2020.12.039.","journal-title":"Int. J. Infect. Dis."},{"key":"2968_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.932408","volume":"13","author":"J. Bigay","year":"2022","unstructured":"Bigay, J., Le Grand, R., Martinon, F., and Maisonnasse, P. (2022) Vaccine-associated enhanced disease in humans and animal models: lessons and challenges for vaccine development, Front. Microbiol., 13, 932408, \nhttps:\/\/doi.org\/10.3389\/fmicb.2022.932408.","journal-title":"Front. Microbiol."},{"key":"2968_CR35","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1128\/JVI.76.6.2827-2834.2002","volume":"76","author":"C. Guillon","year":"2002","unstructured":"Guillon, C., Schutten, M., Boers, P. H. M., Gruters, R. A., and Osterhaus, A. D. M. E. (2002) Antibody-mediated enhancement of human immunodeficiency virus type 1 infectivity is determined by the structure of gp120 and depends on modulation of the gp120-CCR5 interaction, J.\u00a0Virol., 76, 2827-2834, \nhttps:\/\/doi.org\/10.1128\/JVI.76.6.2827-2834.2002.","journal-title":"J.\u00a0Virol."},{"key":"2968_CR36","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1016\/j.vaccine.2016.04.083","volume":"34","author":"B. S. Graham","year":"2016","unstructured":"Graham, B. S. (2016) Vaccines against respiratory syncytial virus: the time has finally come, Vaccine, 34, 3535-3541, \nhttps:\/\/doi.org\/10.1016\/j.vaccine.2016.04.083.","journal-title":"Vaccine"},{"key":"2968_CR37","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","volume":"89","author":"H. W. Kim","year":"1969","unstructured":"Kim, H. W., Canchola, J. G., Brandt, C. D., Pyles, G., Chanock, R. M., Jensen, K., and Parrott, R. H. (1969) Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine, Am. J. Epidemiol., 89, 422-434, \nhttps:\/\/doi.org\/10.1093\/oxfordjournals.aje.a120955.","journal-title":"Am. J. Epidemiol."},{"key":"2968_CR38","doi-asserted-by":"publisher","DOI":"10.34133\/jbioxresearch.0034","volume":"8","author":"M. R. Kumbhare","year":"2025","unstructured":"Kumbhare, M. R., Chandak, S. M., Dukare, A. B., Kshatriya, V. V., and Velhal, S. S. (2025) An updated comprehensive review of the dengue vaccine: development, mechanism, efficacy, and safety, J. Bio X. Res., 8, 0034, \nhttps:\/\/doi.org\/10.34133\/jbioxresearch.0034.","journal-title":"J. Bio X. Res."},{"key":"2968_CR39","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.vaccine.2008.10.087","volume":"27","author":"W. Huisman","year":"2009","unstructured":"Huisman, W., Martina, B. E., Rimmelzwaan, G. F., Gruters, R. A., and Osterhaus, A. D. (2009) Vaccine-induced enhancement of viral infections, Vaccine, 27, 505-512, \nhttps:\/\/doi.org\/10.1016\/j.vaccine.2008.10.087.","journal-title":"Vaccine"},{"key":"2968_CR40","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41577-020-0323-4","volume":"20","author":"P. J. Hotez","year":"2020","unstructured":"Hotez, P. J., Corry, D. B., and Bottazzi, M. E. (2020) COVID-19 vaccine design: the Janus face of immune enhancement, Nat. Rev. Immunol., 20, 347-348, \nhttps:\/\/doi.org\/10.1038\/s41577-020-0323-4.","journal-title":"Nat. Rev. Immunol."},{"key":"2968_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.901217","volume":"13","author":"L. Wieczorek","year":"2022","unstructured":"Wieczorek, L., Zemil, M., Merbah, M., Dussupt, V., Kavusak, E., Molnar, S., Heller, J., Beckman, B., Wollen-Roberts, S., Peachman, K. K., Darden, J. M., Krebs, S., Rolland, M., Peel, S. A., and Polonis, V. R. (2022) Evaluation of antibody-dependent Fc-mediated viral entry, as compared with neutralization, in SARS-CoV-2 infection, Front. Immunol., 13, 901217, \nhttps:\/\/doi.org\/10.3389\/fimmu.2022.901217.","journal-title":"Front. Immunol."},{"key":"2968_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.882972","volume":"13","author":"C. Gartlan","year":"2022","unstructured":"Gartlan, C., Tipton, T., Salguero, F. J., Sattentau, Q., Gorringe, A., and Carroll, M. W. (2022) Vaccine-associated enhanced disease and pathogenic human coronaviruses, Front. Immunol., 13, 882972, \nhttps:\/\/doi.org\/10.3389\/fimmu.2022.882972.","journal-title":"Front. Immunol."},{"key":"2968_CR43","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.mayocp.2020.06.028","volume":"95","author":"M. J. Joyner","year":"2020","unstructured":"Joyner, M. J., Bruno, K. A., Klassen, S. A., Kunze, K. L., Johnson, P. W., Lesser, E. R., Wiggins, C. C., Senefeld, J. W., Klompas, A. M., Hodge, D. O., Shepherd, J. R. A., Rea, R. F., Whelan, E. R., Clayburn, A. J., Spiegel, M. R., Baker, S. E., Larson, K. F., Ripoll, J. G., Andersen, K. J., Buras, M. R., and Wright, R. S. (2020) Safety Update: COVID-19 convalescent plasma in 20,000 hospitalized patients, Mayo Clin. Proc., 95, 1888-1897, \nhttps:\/\/doi.org\/10.1016\/j.mayocp.2020.06.028.","journal-title":"Mayo Clin. Proc."},{"key":"2968_CR44","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.ijid.2020.09.015","volume":"100","author":"J. Wen","year":"2020","unstructured":"Wen, J., Cheng, Y., Ling, R., Dai, Y., Huang, B., Huang, W., Zhang, S., and Jiang, Y. (2020) Antibody-dependent enhancement of coronavirus, Int. J. Infect. Dis., 100, 483-489, \nhttps:\/\/doi.org\/10.1016\/j.ijid.2020.09.015.","journal-title":"Int. J. Infect. Dis."},{"key":"2968_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-022-00566-x","volume":"7","author":"M. G. Byazrova","year":"2022","unstructured":"Byazrova, M. G., Astakhova, E. A., Minnegalieva, A. R., Sukhova, M. M., Mikhailov, A.\u00a0A., Prilipov, A.\u00a0G., Gorchakov, A.\u00a0A., and Filatov, A.\u00a0V. (2022) Anti-Ad26 humoral immunity does not compromise SARS-COV-2 neutralizing antibody responses following Gam-COVID-Vac booster vaccination, NPJ Vaccines, 7, 145, \nhttps:\/\/doi.org\/10.1038\/s41541-022-00566-x.","journal-title":"NPJ Vaccines"}],"container-title":["Biochemistry (Moscow)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297925602795.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1134\/S0006297925602795","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297925602795.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T11:02:32Z","timestamp":1779361352000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1134\/S0006297925602795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2968"],"URL":"https:\/\/doi.org\/10.1134\/s0006297925602795","relation":{},"ISSN":["0006-2979","1608-3040"],"issn-type":[{"value":"0006-2979","type":"print"},{"value":"1608-3040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"29 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval and consent to participate.\n                      This work does not contain any studies involving human or animal subjects.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}},{"value":"Conflict of interest.\n                      The authors of this work declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}